MANSFIELD, MA – May 12, 2025 – Mansfield Bio-Incubator proudly announces the Third BIOINC Pitch Competition line-up, offering $80,000 in prizes. The competition is set to take place on June 12, 2025.
The event will feature seven members of the Mansfield Bio-Incubator, who went through selection rounds across various sectors: therapeutics, devices, diagnostics, and digital health.
· Opprtna Therapeutics – Empowering health through precision aptamer therapeutics.
· Trivoke Therapeutics – Harnessing innate and adaptive immunity for immediate tumor control and lasting cancer defense.
· Boston Interactome – Decoding the human protein interactome for next generation therapies.
· Stapgen – Pioneering the early detection and prevention of Type 2 Diabetes.
· Predictive Healthcare – An AI-based postoperative surgical site infection monitoring.
· Neshima Medical – A paradigm-shifting technology for the delivery of therapeutics to the lungs.
· Novaurum BioSciences – Pioneering nanotechnology for life-changing medical devices
A limited number of contestants may be added to the roster if they meet the qualification requirements.
Participants will deliver a 5-minute pitch, taking advantage of this unique opportunity to gain visibility, receive mentorship, and compete for funding. The BIOINC Pitch Competition series also acts as a gateway for attracting investors and exploring the benefits of participating in BIOINC’s borderless life science ecosystem.
The five-member Judging Panel will consist of investors, industry and academic experts:
David Fogel (Swifton, Managing Director), Eugene Buff (Director of Health Science Entrepreneurship and Innovation, Northeastern University), Jeff Berman (Co-Founder, Big Tree Innovation Fund), Courtney Metz (Site Head, Harvard Life Labs, LabCentral), James Ehret (Managing Director, Life Sciences, Bank of California).
“The diversity of fields represented in this year’s competition, along with the global footprint of the participating startups, reflects the continued momentum of our thriving life science ecosystem,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “This event offers an exceptional opportunity for emerging companies to increase visibility, build valuable connections, benefit from expert mentorship, and attract the funding needed to propel their innovations forward.”
For more information, contact Alex Shlyankevich, Director of Investments, at alexsh@bioinc.org.
About Mansfield Bio-Incubator
Through its ecosystem activities, Mansfield Bio-Incubator offers comprehensive support to early-stage life science companies, including mentoring programs, pitch competitions, networking opportunities, investor exposure, MassBio/MassMEDIC memberships, and state-of-the-art laboratory and office space. Its mission is to foster innovation in healthcare by assisting startups in navigating growth and development challenges.
For media inquiries, please contact: info@bioinc.org
Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048